Brief report: MECP2 mutations in people without Rett syndrome.

Suter et al. (2014) looked at people who carry a MECP2 mutation but do not have classic Rett syndrome. They ran a case series to map the wider range of symptoms that can travel with this gene change.

The group included children with global delay, OCD, and ADHD. None showed the hand-wringing or loss of speech that doctors usually link to Rett.

The team showed that MECP2 is no longer a "Rett-only" gene. Kids can have the mutation and still speak, walk, and use their hands.

The main clue is a mix of slow development plus OCD or ADHD traits. This pattern should trigger genetic testing even when Rett signs are missing.

Falcomata et al. (2012) found two new MECP2 mutations in Lebanese girls who also had mild, non-classic features. Both papers widen the known picture of what MECP2 can look like.

Taylor et al. (1993) tracked classic Rett cases for three years and saw tiny gains in social acts. Bernhard flips the lens: the same gene can act in people who never lose those skills.

Crettenden et al. (2018) later used tDCS to boost language in three classic Rett girls. Bernhard’s work hints that such tech might also help the new, milder group who still have some speech.

If a child on your caseload shows global delay mixed with rigid or hyper behavior, think beyond ADHD or OCD alone. Ask the medical team to check MECP2. Early gene info can steer you toward seizure watches, sleep plans, and family counseling that Rett clinics already use. You also avoid wrong labels and can set goals that fit a milder trajectory.